ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0060088;auditory receptor cell stereocilium organization;7.0;1.0;0.8509193652572005;9.628524252492122;22.00145371568439;7.379178354882098;7.363688558411388E-4;0.728290889492758;[CLIC5]
GO:1902476;chloride transmembrane transport;8.0;1.0;0.875;9.628524252492122;110.5175749436453;5.311165509025885;0.0036989237740038075;0.6466132511260384;[CLIC5, BEST3]
GO:0006486;protein glycosylation;7.0;0.6181399273706679;0.6599893289425345;8.590536585640447;174.0766208890209;4.3090134865453384;0.005826187842367879;0.5712825153487487;[DPM3, COG3, FUT11, SYVN1, MAN1B1, TRAK1, GALNT10]
GO:0008343;adult feeding behavior;3.0;1.0;0.6981203125901445;9.628524252492122;24.575257889458463;7.474488534686424;8.225117652639858E-4;0.5803660038532718;[USP46]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CDK9, TBP, POLR2B, NPPA, TAF7, POLR2G, RORA, MED6, GTF2I]
GO:0008589;regulation of smoothened signaling pathway;6.0;0.7671156992804218;0.7066781622303554;9.0689084645567;41.8512380110395;5.500407508664414;0.0014007232725606145;0.6044114083783503;[IFT122, RORA]
GO:0032922;circadian regulation of gene expression;6.0;1.0;0.8231203125901445;9.628524252492122;31.18462308171688;5.769740442447999;0.0010437212702063816;0.618185107137305;[PPP1CB, PPP1CC, HDAC1, RORA]
GO:0046068;cGMP metabolic process;10.0;0.8933024483968273;0.861892236059334;9.557065288509976;715.8276931067899;6.311337724880743;0.023958108685185667;0.7380031166185408;[NPPA, RORA]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[CDKN1C, CIITA, HDAC3, HDAC1, NAB1, FOXG1, ARID4A, OTUD7B, IKZF2, YY1, NIPBL, SAP130, TPR, DPF2, TRIM24, EP300, LRRFIP1, SUDS3, ZNF564, ZNF189, TLE4, IRX1, DR1, UBE2I, NFYC, EID1, ILF3, HIST3H2A, CNOT1, NFIC, SP3, MTF2, ZNF658, LCOR, TAF7]
GO:0043030;regulation of macrophage activation;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;27.112248267214866;6.088194173566533;9.074225500643868E-4;0.63447084575632;[KARS, RORA]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[CDKN1C, CIITA, ONECUT2, ARID4A, RORA, DDX41, HOXC13, AATF, IKZF2, YY1, NIPBL, NUP62, DPF2, TRIM24, EP300, ZNF564, IER2, TBP, NCOA6, ARNT, SENP2, MED6, ILF3, GAL, KARS, MTF2, TFEC, HDAC3, HDAC1, WBP2, RLF, DVL3, SCAP, TBX1, ZNF462, DR1, NFYC, PBX3, GRHL1, USF2, FLI1, SETX, CDK9, CD4, TFCP2, COPS5, NFIC, SP3, TAF7, CAMK1]
GO:0010738;regulation of protein kinase A signaling;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;45.070113835906206;6.599019797332524;0.001508456149618737;0.6883935445785896;[AKAP11]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFNAR2, BECN1, ITCH, ILF3, POLR3C, DDX41, SERINC3, UNC13D, EXOC1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[NPEPPS, UBQLN1, RORA, ATP7A, KCNK3]
GO:0017148;negative regulation of translation;8.0;0.6493065804076676;0.6996532902038338;9.081980546124052;1114.6737408694362;4.99795013456894;0.03730712696566269;0.6305954023103058;[EIF4ENIF1, ILF3, CNOT1, TPR, CNOT10, EIF4E2, CNOT8]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[RAB3B, PRKCSH, DOCK8, DGKA, IL5RA, DEFB1, BBC3, POLB, AKAP11, RPS6KA2, CASP2, EP300, RAB8B, CCR2, IFNAR2, GFRA2, ERN1, BCR, GAL, KARS, ALS2, ELMO1, DOCK2, KPNB1, EXOC1, CLEC16A, ITPR2, KRCC1, CRHR1, RAB21, ABR, NUAK1, GNG2, PABPN1, TIFA, STK38, DVL3, STK38L, NCAM1, ECT2, IFT122, CNOT10, SETX, CNOT6, SNRK, ITCH, IRAK1BP1, PTPRA, CNOT1, RAB18, CCM2, NMUR1, CAMK1, CNOT8, CALM1]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[ARNT, RORA]
GO:0021702;cerebellar Purkinje cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;49.9926366230673;7.57984905034425;0.0016732085573221292;0.710754145523778;[HERC1, RORA, ATP7A]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[BCR, ABR, RORA]
GO:0010906;regulation of glucose metabolic process;7.0;0.6763753087927167;0.6891070196535589;8.753055515138222;59.50955823828417;5.171903441692378;0.00199173135911005;0.615410747783455;[RORA]
GO:0006809;nitric oxide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;241.09966064176743;7.212124270218933;0.008069388666072628;0.6919486831672181;[RORA]
GO:0072539;T-helper 17 cell differentiation;11.0;1.0;0.9324289523296623;9.628524252492122;473.70362526189734;8.67846133901236;0.01585443403193107;0.8762458687964789;[RORA]
GO:0036315;cellular response to sterol;6.0;0.8436909121759173;0.7449657686781032;9.392135474427892;230.17252427133502;6.943860283624253;0.007703667245538525;0.6782296504172152;[RORA]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[CEP70, CLASP1, PAFAH1B1]
GO:0070507;regulation of microtubule cytoskeleton organization;7.0;0.6073376606709605;0.6545881955926808;8.242229891372231;33.71079736555127;4.584116776790259;0.0011282700500770656;0.5853513104054853;[SENP6, PDCD6IP, STAG2, TPR, NUP62, CEP70, CIB1, CLASP1, PAFAH1B1]
GO:0035065;regulation of histone acetylation;10.0;0.6997970393407541;0.7651395315312974;9.171765849996406;181.04600604238792;5.845247994956144;0.006059446891411651;0.7141672661548077;[SETD5, EID1, WBP2, TAF7]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[OTUD7B, RORA]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CIITA, HDAC3, ONECUT2, HDAC1, WBP2, ARID4A, RORA, DDX41, HOXC13, AATF, IKZF2, RLF, YY1, NIPBL, DPF2, EP300, SCAP, ZNF564, IER2, TBX1, ZNF462, DR1, NCOA6, NFYC, PBX3, ARNT, SENP2, GRHL1, USF2, FLI1, MED6, SETX, CDK9, TFCP2, GAL, COPS5, NFIC, SP3, MTF2, TFEC, TAF7, CAMK1]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[IL5RA, NUAK1, ZMYM2, PABPN1, RPS6KA2, STK38, TRIM24, STK38L, NCAM1, CSNK2A1, CLK4, GFRA2, SETX, CLK1, ERN1, CDK9, BCR, SNRK, ILF3, PAN3, KARS, PTPRA, FASTKD5, CCM2, CAMK1, CALM1]
GO:0042753;positive regulation of circadian rhythm;4.0;0.8259837884571596;0.6629918942285797;9.040737587590003;21.56673843117642;6.8867018697843045;7.21819326487013E-4;0.6021862538851576;[RORA]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[NCOA6, WBP2, TAF7, RORA]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[CIITA, HDAC3, HDAC1, FOXG1, OTUD7B, IKZF2, YY1, NIPBL, SAP130, TPR, EP300, LRRFIP1, SUDS3, ZNF564, ZNF189, TLE4, IRX1, DR1, UBE2I, EID1, CNOT1, NFIC, SP3, MTF2, LCOR, TAF7]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CEP70, FBXL15, CLASP1, PAFAH1B1]
GO:0045595;regulation of cell differentiation;4.0;0.3376379861120121;0.41881899305600606;5.249000748036359;23.33457331431992;2.3564947222696686;7.809871690777242E-4;0.3705112496850823;[ANKRD17, HDAC1, ITGB3, FOXG1, CIB1, RORA, TRAK1, GLG1, CYB5D2, RAB21, EIF4ENIF1, PPP1CC, NIPBL, KIAA1109, DVL3, EP300, ECT2, FADS1, CLASP1, ZNF365, CCR2, TBX1, SEMA6B, TMEM30A, TMEM176A, ARNT, THOC2, GRHL1, UNC13D, SETX, CDK9, OLFM1, EID1, ITCH, CD4, GAL, SYNJ1, ARPC2, CAMK1, PAFAH1B1, C1QC]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[IFNAR2, BBS2, CIITA, CD4, KARS, SDC1, PSME2, IL5RA, CIB1, NCAM1, RORA, CCR2]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[ABCA3, SDC1]
GO:0034765;regulation of ion transmembrane transport;6.0;0.45556283921517005;0.5509017321977295;6.676594601596523;33.03735142972539;3.697140432584879;0.0011057304206669666;0.512192246247148;[KCNK6, CLIC5, AHCYL1, GAL, NPPA, CACNA2D3, UBQLN1, FXYD5, ATP7A, CALM1, CRHR1]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[CIB1, RORA]
GO:0032228;regulation of synaptic transmission, GABAergic;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;30.61939422688933;6.311337724880743;0.001024803569108247;0.6736814700148209;[USP46]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[ILF3]
GO:0030522;intracellular receptor signaling pathway;5.0;0.6547035408479693;0.617592782284905;7.98629651723503;23.17027026302992;4.6122876537569555;7.75488093814194E-4;0.5261136169673617;[TBX1, ITCH, NCOA6, WBP2, TAF7, ARNT, RORA]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[USP46, BECN1, WDR48, OTUD7B, USP39, YY1, PSMD8, POLB, VCPIP1, COPS5, PSMB1, PSME2, USP51]
GO:0060850;regulation of transcription involved in cell fate commitment;11.0;0.7369933605727446;0.8009256326160346;9.190269321560967;252.6466751378032;6.943860283624253;0.00845585684961658;0.7875382901567328;[RORA]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[PHF3, SETD5, CIITA, ONECUT2, NAB1, INTS10, ARID4A, HOXC13, IKZF2, CHD1, YY1, NIPBL, ZMYM2, SAP130, NUP62, DPF2, TRIM24, ZNF768, EP300, ZNF326, LRRFIP1, ZNF688, ZNF564, IER2, GTF2I, TLE4, TBP, CSNK2A1, BUD31, COMMD3, ARNT, ZFX, SND1, MED29, ERN1, EID1, ILF3, ZNF519, TFEC, LCOR, VGLL4, ZNF394, HDAC3, HDAC1, WBP2, FOXG1, RLF, POLR2B, POLR2G, SUDS3, ASCC3, ZNF189, TRAPPC2, TBX1, ZNF462, DR1, NFYC, INTS3, PBX3, CNOT10, GRHL1, USF2, FLI1, SOX30, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, POLR3C, NFIC, SP3, ZNF658, INTS4, TAF7, CNOT8, ZNF532, ZNF410]
GO:0007286;spermatid development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;5.370354380416217;0.0024359751381706407;0.5648811846224242;[SPAG6, CIB1, IQCG]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[RAB3B, ARID4A, IL5RA, GALNT10, YY1, PPP1CB, PSMD8, PPP1CC, NPEPPS, HERC1, RPL36AL, RPS6KA2, FNTB, NPPA, TRIM24, EP300, TGM6, C18orf25, CSNK2A1, VPS33B, COG3, SSU72, MRPS18A, ERN1, BCR, DPM3, ILF3, KARS, KCTD10, PSME2, ANAPC5, FUT11, RLF, ANAPC11, VCPIP1, NUAK1, STK38, STK38L, USP51, SUDS3, DR1, UBE2I, ABCA3, LNPEP, CLK4, SETX, CLK1, CDK9, PAN3, COPS5, PTPRA, MAN2B2, FBXL3, CALM1, PIGS, WDR48, PRKCSH, SERPINA10, CLTA, OTUD7B, USP39, MSLN, SENP6, POLB, TRIM9, ZMYM2, SUMO3, TRIM69, ATP7A, PCMTD1, VKORC1, USP46, ZFP91, DUSP28, SENP2, GFRA2, PTP4A1, DDB1, DUSP23, FASTKD5, MAN1B1, BECN1, HDAC3, HDAC1, MRPS36, RNF38, ZDHHC24, TRAK1, PPM1G, PABPN1, PSMB1, NCAM1, RFFL, RPL19, SYVN1, FBXL15, POLE4, SNRK, ITCH, CCM2, CAMK1]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[RORA]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[CLIC5, SPHK2, NPPA, LNPEP, COMT, CRHR1]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[NAB1, ARID4A, CIB1, RORA, IKZF2, YY1, ADORA3, SAP130, DPF2, TRIM24, EP300, ZNF326, ZNF688, FADS1, ZNF564, IER2, GTF2I, TLE4, CSNK2A1, SSU72, SND1, MED6, ERN1, EID1, THAP6, ILF3, KARS, TRIM14, ZNF394, FOXG1, RLF, TPR, DVL3, SCAP, SUDS3, TRAPPC2, DR1, UBE2I, PBX3, CNOT10, FLI1, SOX30, SETX, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, GOLGB1, SP3, ZNF658, CNOT8, ZNF532, ZNF410, CDKN1C, SETD5, CIITA, ONECUT2, OTUD7B, DDX41, HOXC13, AATF, CHD1, NIPBL, ZMYM2, NUP62, GATAD1, ZNF768, LRRFIP1, TBP, NCOA6, BUD31, ZFP91, COMMD3, ARNT, SENP2, ZFX, MED29, TOX4, GAL, ZNF519, MTF2, TFEC, LCOR, VGLL4, MTPN, HDAC3, HDAC1, WBP2, TRAK1, ASCC3, ZNF189, IRX1, TBX1, ZNF462, NFYC, FBXL15, GRHL1, USF2, ITCH, CD4, HIST3H2A, POLR3C, NFIC, TAF7, CAMK1]
GO:0007288;sperm axoneme assembly;8.0;1.0;0.875;9.628524252492122;92.78469724802203;7.379178354882098;0.0031054203160851054;0.7523715242355574;[BBS2, IQCG]
GO:0006435;threonyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;8.67846133901236;0.006875708083302461;0.8762458687964789;[TARSL2]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[IRAK1BP1, TIFA]
GO:0001662;behavioral fear response;5.0;1.0;0.7902410118609202;9.628524252492122;37.889479621082295;6.375876246018314;0.0012681267845998157;0.6163036195908642;[USP46, ALS2, VDAC3]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[USP46, UBE2I, LRRC29, RNF38, SYVN1, FBXL15, ANAPC11, PSMD8, DDB1, KBTBD4, TRIM9, ITCH, KCTD10, PSMB1, UBQLN1, FBXL3, ANAPC5, USP51, MAN1B1, RFFL, C18orf25]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[CEP70, CLASP1, PAFAH1B1]
GO:0042692;muscle cell differentiation;4.0;0.6873818243518346;0.5936909121759173;8.242229891372231;21.066225782797595;5.382624473008031;7.050676185779127E-4;0.525267665867267;[MTPN, RORA]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[YY1, RORA]
